Professor | Bairong Xia | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Bairong Xia
Contact Information	xiabairong9999@126.com
Language ability	Chinese, English
Province	Anhui

Upload Avatar (500 x 500)

Name

Bairong Xia

Contact Information

xiabairong9999@126.com

Language ability

Chinese, English

Province

Anhui

University/Lab Affiliation and Title	University of Science and Technology of China
Faculty	Mayo Clinic College of Medicine
Academic Background & Achievements	2018.9-2021.6 Postdoctoral: Harbin Medical University, Public Health and Preventive Medicine 2014.9–2017.6 PhD: Harbin Medical University, Oncology 2009.9–2012.6 Master's: Jiamusi University, Obstetrics and Gynecology 1996.9–2001.7 Bachelor's: Mudanjiang Medical College, Clinical Medicine
Work Experience	2020.6-present - The First Affiliated Hospital of USTC West District - Chief Physician in Gynecologic Oncology 2018.1-2020.6 - Harbin Medical University Cancer Hospital - Chief Physician in Gynecologic Oncology 2012.9-2018.1 - Harbin Medical University Cancer Hospital - Deputy Chief Physician in Gynecologic Oncology
Awards	2024.02: Ninth Batch of Academic and Technical Leaders of Anhui Province 2023.12: People's Good Doctor 2023.12: Second Prize in the Fourth Medical Science and Technology Innovation Competition, Innovation Management Category 2023.02: First Prize in Hubei Province Science and Technology Progress Award 2022.11: First Anhui 'Young Jianghuai Famous Doctor' 2022.08: Second Anhui 'Good Doctor' 2022.05: Most Beautiful Science and Technology Worker in Shushan District, Hefei City, Anhui Province 2021.09: First Prize in National Maternal and Child Health Science and Technology Award, Natural Science Award 2019.06: First Prize in Chinese Oncology Tomorrow's Famous Doctor

University/Lab Affiliation and Title

University of Science and Technology of China

Faculty

Mayo Clinic College of Medicine

Academic Background & Achievements

2018.9-2021.6 Postdoctoral: Harbin Medical University, Public Health and Preventive Medicine
2014.9–2017.6 PhD: Harbin Medical University, Oncology
2009.9–2012.6 Master's: Jiamusi University, Obstetrics and Gynecology
1996.9–2001.7 Bachelor's: Mudanjiang Medical College, Clinical Medicine

Work Experience

2020.6-present - The First Affiliated Hospital of USTC West District - Chief Physician in Gynecologic Oncology
2018.1-2020.6 - Harbin Medical University Cancer Hospital - Chief Physician in Gynecologic Oncology
2012.9-2018.1 - Harbin Medical University Cancer Hospital - Deputy Chief Physician in Gynecologic Oncology

Awards

2024.02: Ninth Batch of Academic and Technical Leaders of Anhui Province
2023.12: People's Good Doctor
2023.12: Second Prize in the Fourth Medical Science and Technology Innovation Competition, Innovation Management Category
2023.02: First Prize in Hubei Province Science and Technology Progress Award
2022.11: First Anhui 'Young Jianghuai Famous Doctor'
2022.08: Second Anhui 'Good Doctor'
2022.05: Most Beautiful Science and Technology Worker in Shushan District, Hefei City, Anhui Province
2021.09: First Prize in National Maternal and Child Health Science and Technology Award, Natural Science Award
2019.06: First Prize in Chinese Oncology Tomorrow's Famous Doctor

Areas of Focus	Molecular mechanisms and targeted therapy in gynecological oncology Tumor microenvironment and treatment resistance Comprehensive and immunotherapy in gynecological oncology
Publications	Multi-omics characterization of silent and productive HPV integration in cervical cancer, Junpeng Fan, Yu Fu, Wenju Peng, Xiong Li, Yuanming Shen, Ensong Guo, Funian Lu, Shengtao Zhou, Si Liu, Bin Yang, Xu Qin, Dianxing Hu, Rourou Xiao, Xi Li, Siqi Yang, Cunzhong Yuan, Yao Shu, He Huang, Ting Wan, Yanan Pi, Shuxiang Wang, Wenjuan Chen, Haixia Wang, Lin Zhong, Li Yuan, Baogang Wen, Beihua Kong, Gordon B. Mills, Dongling Zou, Bairong Xia, Kun Song, Gang Chen, Ding Ma, Chaoyang Sun, 2023 Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer, Huang X, Li XY, Shan WL, Chen Y, Zhu Q, Xia BR, 2023 Laparoendoscopic single-site surgery for deep infiltrating endometriosis based on retroperitoneal pelvic spaces anatomy: a retrospective study, Zhang S, Yu H, Dong Z, Chen Y, Shan W, Zhang W, Tang H, Chen M, Wei W, Shi R, Xia B, Chen J, 2023 The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells, Sun L, Ji WX, Li Y, Li ZL, Duan CC, Xia BR, Xiao L, 2023 Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy, Li XY, Pi YN, Chen Y, Zhu Q, Xia BR, 2022 Safety and Feasibility of Vaginal Delivery in Full-Term Pregnancy After Transvaginal-Natural Orifice Transluminal Endoscopic Surgery: A Case Series, Zhang, Shoufeng, Zhiyong Dong, Junling Liu, Zhenyue Qin, Huihui Wang, Mingyue Bao, Weiwei Wei, Ruxia Shi, Jiming Chen, and Bairong Xia, 2022 IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors, Zhang Y, Zhang K, Jia H, Xia B, Zang C, Liu Y, Qian L, Dong J, 2022 A novel attention-guided convolutional network for the detection of abnormal cervical cells in cervical cancer screening, Cao L, Yang J, Rong Z, Li L, Xia B, You C, Lou G, Jiang L, Du C, Meng H, Wang W, Wang M, Li K, Hou Y, 2021

Areas of Focus

Molecular mechanisms and targeted therapy in gynecological oncology
Tumor microenvironment and treatment resistance
Comprehensive and immunotherapy in gynecological oncology

Publications

Multi-omics characterization of silent and productive HPV integration in cervical cancer, Junpeng Fan, Yu Fu, Wenju Peng, Xiong Li, Yuanming Shen, Ensong Guo, Funian Lu, Shengtao Zhou, Si Liu, Bin Yang, Xu Qin, Dianxing Hu, Rourou Xiao, Xi Li, Siqi Yang, Cunzhong Yuan, Yao Shu, He Huang, Ting Wan, Yanan Pi, Shuxiang Wang, Wenjuan Chen, Haixia Wang, Lin Zhong, Li Yuan, Baogang Wen, Beihua Kong, Gordon B. Mills, Dongling Zou, Bairong Xia, Kun Song, Gang Chen, Ding Ma, Chaoyang Sun, 2023
Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer, Huang X, Li XY, Shan WL, Chen Y, Zhu Q, Xia BR, 2023
Laparoendoscopic single-site surgery for deep infiltrating endometriosis based on retroperitoneal pelvic spaces anatomy: a retrospective study, Zhang S, Yu H, Dong Z, Chen Y, Shan W, Zhang W, Tang H, Chen M, Wei W, Shi R, Xia B, Chen J, 2023
The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells, Sun L, Ji WX, Li Y, Li ZL, Duan CC, Xia BR, Xiao L, 2023
Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy, Li XY, Pi YN, Chen Y, Zhu Q, Xia BR, 2022
Safety and Feasibility of Vaginal Delivery in Full-Term Pregnancy After Transvaginal-Natural Orifice Transluminal Endoscopic Surgery: A Case Series, Zhang, Shoufeng, Zhiyong Dong, Junling Liu, Zhenyue Qin, Huihui Wang, Mingyue Bao, Weiwei Wei, Ruxia Shi, Jiming Chen, and Bairong Xia, 2022
IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors, Zhang Y, Zhang K, Jia H, Xia B, Zang C, Liu Y, Qian L, Dong J, 2022
A novel attention-guided convolutional network for the detection of abnormal cervical cells in cervical cancer screening, Cao L, Yang J, Rong Z, Li L, Xia B, You C, Lou G, Jiang L, Du C, Meng H, Wang W, Wang M, Li K, Hou Y, 2021

Gynecological Oncology Molecular Mechanisms Targeted Therapy Tumor Microenvironment Treatment Resistance Comprehensive Therapy Immunotherapy Cancer Research Oncology Clinical Studies

Jia Bei Wang - University of Science and Technology of China

Ming Li - University of Science and Technology of China

Wei-Fu Lv - University of Science and Technology of China

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us